Drug Shortage Report for STATEX SUPPOSITORIES 20MG
Report ID | 19877 |
Drug Identification Number | 00596965 |
Brand name | STATEX SUPPOSITORIES 20MG |
Common or Proper name | Statex |
Company Name | PALADIN PHARMA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 20MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL |
Packaging size | Box of 10 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-11-30 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-12-14 |
Shortage status | Resolved |
Updated date | 2021-12-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-12-15 | English | Compare |
v6 | 2021-12-14 | French | Compare |
v5 | 2021-12-14 | English | Compare |
v4 | 2021-12-14 | English | Compare |
v3 | 2021-12-01 | English | Compare |
v2 | 2017-08-18 | French | Compare |
v1 | 2017-08-18 | English | Compare |
Showing 1 to 7 of 7